MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: GTCbio - Biopharmaceutical Conference
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thomas Hamilton to Speak About the Cytokine Regulation at Cytokines Conference on January 29-31, 2014 in San Diego, California - Thomas Hamilton will present about “Regulation of TLR-Induced Cytokine Expression by Environmental Stress” at the 12th Cytokines & Inflammation Conference, to be held January 29-31, 2014 in San Diego, CA
Thomas Hamilton to Speak About the Cytokine Regulation at Cytokines Conference on January 29-31, 2014 in San Diego, California

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/10/07 - Thomas Hamilton will present about “Regulation of TLR-Induced Cytokine Expression by Environmental Stress” at the 12th Cytokines & Inflammation Conference, to be held January 29-31, 2014 in San Diego, CA.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Hamilton currently serves as the Chairman of the Department of Immunology at the Lerner Research Institute of the Cleveland Clinic Foundation, where his research focuses on studying the regulation of inflammatory cytokine and chemokine gene expression. His laboratory has made substantial contributions to the understanding of both transcriptional and post-transcriptional control mechanisms regulating innate inflammatory responses in myeloid and non-myeloid cell populations.

He will discuss how cellular stress can amplify the expression of selected inflammatory cytokines in myeloid cell populations. For example, TLR-stimulated CXCL1 and CXCL2 chemokine mRNA levels are enhanced more than ten-fold in stressed macrophages, while mRNAs encoding CCL5 and CXCL10 are not. Other pro-inflammatory cytokines that show elevated levels of stress include TNFa, IL-1a, and IL-6.

Stress responses also enhance chemokine protein levels during peritoneal inflammation. TLR4 is the most sensitive, though other TLR responses are also enhanced. Stress-enhanced chemokine gene expression is mediated by altered transcription, but NFkB activation, though necessary, does not appear to be the target of stress.

Similarly, while the IRF3 transcription factor is linked to TLR4 signaling, IRF3 is not required for stress sensitivity. Though mediators of endoplasmic reticulum stress (IRE-1, XBP-1, and CHOP) have been implicated in altered inflammatory cytokine responses, they are not required for amplification of TLR4-induced chemokine expression. Rather, RIP1, a kinase that participates in TLR3 andTLR4/TRIF signaling, is required through a pathway that involves stress-dependent increases in RIP1 protein levels and activation via ubiquitinylation.

Dr. Hamilton will discuss how these findings, which identify novel mechanisms for modulating the magnitude and duration of selective TLR-induced chemokine and cytokine gene expression, further establish the importance of environmental stress in coordinating the outcomes of cellular and tissue injury.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thomas Hamilton to Speak About the Cytokine Regulation at Cytokines Conference on January 29-31, 2014 in San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil
Ipsen Enters into an Option Agreement with IRICoR and Université de Montréal for A Discovery-stage Oncology Program
Ipsen Announces Positive Topline Results from Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX®
Ipsen Data Presented During ENETS Annual Conference 2020 Capture New Patient and Healthcare Professional Insights in the Treatment of NETs
Global Pharmaceutical Contract Manufacturing Organization Market to Reach 2.14 Billion by 2024 Finds Frost & Sullivan
Ipsen’s Palovarotene Clinical Program in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Limelon Advertising, Co.





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)